View this email in your browser
TrialStat News for January 2020
Happy New Year!

To kick off 2020, TrialStat has launched a new monthly newsletter focused on highlighting breaking news stories, exciting industry advancements, and positive patient stories from within our community.

It’s our 20-20 vision to expand our connected network of business partners, clients, industry colleagues, and those interested in the clinical research space to bring curated, reliable content to your inbox each month with quality stories relevant to you! We welcome hearing from each of you if you have something to share that might be relevant to a wider audience.

While you are always welcome to unsubscribe through the link at the bottom of this email, we hope to stay in touch and continue to share useful and interesting news and content while keeping opportunities for collaboration open. Please let us know what you think; we look forward to your comments and suggestions!

Thank you from the entire TrialStat Team!

SOSV Announces Launch of IndieBio New York

A  fantastic opportunity for life science startups in the New York area!

“We’re doubling down on life sciences,” said Sean O’Sullivan, Managing General Partner of SOSV. “We are looking to bring what IndieBio has created for the California life science industry to the East Coast. New York is a great hub for life sciences research and financing, and will be a natural center for life science startups.”

Continue Reading The Press Release

Google Shows AI Can Spot Breast Cancer Better Than Doctors

According to new research from Google Health, AI can more accurately detect breast cancer than physicians.

"The technology’s reading of mammograms reduced both false positives, where healthy patients are mistakenly diagnosed with the disease, and false negatives, where the cancer is missed, the Alphabet Inc. unit said in a blog post on Wednesday. The system reduced false positives by 5.7% in the U.S., according to data from more than 28,000 mammograms performed there and in the U.K."

Continue Reading Article

New radiotracer offers opportunities for earlier intervention after heart attack

 Reston, VA–Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage. According to research published in the December issue of The Journal of Nuclear Medicine, 68Ga-FAPI-04 positron emission tomography (PET) can effectively image fibroblast activation after myocardial infarction, identifying a time window during which cardiac fibrosis can be prevented and the disease course altered.“

Continue Reading Article

Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials

Sponsors and technology vendors need to work together to develop innovative new ways to streamline the clinical trial process

Ochsner Health System and Pfizer have embarked on a multi-year alliance to enhance the clinical trial experience and ease participation in clinical research for both patients and healthcare professionals.

Continue Reading Article

Meet The TrialStat Team In Person

Book Your Personalized Demo Today!

To book your personalized demonstration of TrialStat's Unified eClinical Suite, please contact Christopher Kata at 905 999-1957 or by email at
A New Paradigm in Data Management Technology
Learn More About TrialStat
A New Paradigm In Data Management Technology
LinkedIn - TrialStat Solutions Inc.
Copyright © 2020 TrialStat Solutions Inc., All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.